Markets · 1 sources covering this

PB Fintech's 36% bloodbath rattles market, but Jefferies stays bullish. What does it see in Policybazaar parent?

PB Fintech shares plunged a record 36% to a 52-week low, wiping out around Rs 31,430 crore in market value after IRDAI proposed changes to insurance commission structures. While Jefferies flagged a potentially material near-term earnings impact, it retained its ‘Buy’ call on the stock.

Share:WhatsApp X Reddit Facebook

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Economic TimesLean R·1h ago
PB Fintech's 36% bloodbath rattles market, but Jefferies stays bullish. What does it see in Policybazaar parent?
PB Fintech shares plunged a record 36% to a 52-week low, wiping out around Rs 31,430 crore in market value after IRDAI proposed changes to insurance commission structures. While Jefferies flagged a potentially material near-term earnings impact, it retained its ‘Buy’ call on the stock.
Read at Economic Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/c4add37b568d25cd8cbb7db3477ab0f465f50b6e"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="PB Fintech's 36% bloodbath rattles market, but Jefferies stays bullish. What does it see in Policybazaar parent?"></iframe>

PB Fintech's 36% bloodbath rattles market, but Jefferies stays bullish. What does it see in Policybazaar parent?

How 1 sources are covering this

PB Fintech's 36% bloodbath rattles market, but Jefferies stays bullish. What does it see in Policybazaar parent?

More from Markets

240% rally in six months! Defence stock Raymond hits 52-week high; exit or hold? Explained with target, stop-loss, ratio

IPO multibagger ESDS shares hit 5% lower circuit as Q1 net profit more than halves. Time to sell?

Welspun Corp shares rise 4% after US subsidiary bags $412.5 million HFIW pipe order

NSE shares dip below listing price — will it rebound or more pain ahead? | Explained with support, resistance, target

Reader

Trust & legal

Across the network